Exposure to ambient air pollution is widespread and may be detrimental to human brain development and a potential risk factor for Autism Spectrum Disorder (ASD). We conducted a systematic review of the human evidence on the relationship between ASD and exposure to all airborne pollutants, including particulate matter air pollutants and others (e.g. pesticides and metals).
We conducted a comprehensive search of the literature, identified relevant studies using inclusion/exclusion criteria pre-specified in our protocol (registered in PROSPERO, CRD # 42015017890), evaluated the potential risk of bias for each included study and identified an appropriate subset of studies to combine in a meta-analysis. We then rated the overall quality and strength of the evidence collectively across all air pollutants.
Of 1,158 total references identified, 23 human studies met our inclusion criteria (17 case-control, 4 ecological, 2 cohort). Risk of bias was generally low across studies for most domains; study limitations were related to potential confounding and accuracy of exposure assessment methods. We rated the quality of the body of evidence across all air pollutants as “moderate.” From our meta-analysis, we found statistically significant summary odds ratios (ORs) of 1.07 (95% CI: 1.06, 1.08) per 10-μg/m3 increase in PM10 exposure (n = 6 studies) and 2.32 (95% CI: 2.15, 2.51) per 10-μg/m3 increase in PM2.5 exposure (n = 3 studies). For pollutants not included in a meta-analysis, we collectively evaluated evidence from each study in rating the strength and quality of overall evidence considering factors such as inconsistency, imprecision, and evidence of dose-response. All included studies generally showed increased risk of ASD with increasing exposure to air pollution, although not consistently across all chemical components.
After considering strengths and limitations of the body of research, we concluded that there is “limited evidence of toxicity” for the association between early life exposure to air pollution as a whole and diagnosis of ASD. The strongest evidence was between prenatal exposure to particulate matter and ASD. However, the small number of studies in the meta-analysis and unexplained statistical heterogeneity across the individual study estimates means that the effect could be larger or smaller (including not significant) than these studies estimate. Our research supports the need for health protective public policy to reduce exposures to harmful airborne contaminants among pregnant women and children and suggests opportunities for optimizing future research.
Citation: Lam J, Sutton P, Kalkbrenner A, Windham G, Halladay A, Koustas E, et al. (2016) A Systematic Review and Meta-Analysis of Multiple Airborne Pollutants and Autism Spectrum Disorder. PLoS ONE 11(9): e0161851. https://doi.org/10.1371/journal.pone.0161851
Editor: Chandrasekharan Nair Kesavachandran, CSIR-Indian Institute of Toxicology Research, INDIA
Received: May 31, 2016; Accepted: August 14, 2016; Published: September 21, 2016
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The work of JL, PS, ND, TW was supported in part by a grant from Autism Speaks (https://www.autismspeaks.org/) and by a P01 grant from the US Environmental Protection Agency and National Institute of Environmental Health Sciences (https://www3.epa.gov/; http://www.niehs.nih.gov/). NIEHS grant number: PO1ES022841; USEPA grant number: 83543301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Air pollution is a serious public health issue, responsible for over seven million deaths a year worldwide . In addition to mortality, cardiovascular and respiratory diseases have been identified as primary health concerns related to exposure [2–4]. More recently, the central nervous system was proposed as another organ negatively affected by air pollutants , and prenatal air pollution has been identified as having potentially greater impacts than adult exposures .
Air pollution is composed of a large number of compounds coming from a wide variety of sources, notably vehicle and powerplant emissions. Compounds include well-characterized pollutants such as particulate matter (PM) and ozone, and lesser-characterized airborne chemicals like metals and pesticides. Studies of individual components of air pollution have found links to neurodevelopmental outcomes, including effects on intelligence quotient (IQ), language development, executive function, and psychomotor development [7–10]. Studies in animals have also found that developmental exposure to air pollution is related to functional and structural brain effects [11–15].
In particular, a number of studies have reported a relationship to Autism Spectrum Disorder (ASD). ASD is a group of complex neurodevelopmental disabilities defined by a spectrum of behaviors, characterized generally by difficulties with social interaction and communication accompanied by restricted or repetitive behaviors or interests. ASD has well-characterized comorbidities and increasing prevalence, estimated within the United States (US) at 1 in 68 children in 2010 (1.5%) [16, 17]. ASD has few and limited effective treatments and is associated with considerable financial and medical burden; research into its etiology has increased dramatically over the last decade to address the increasing prevalence. Many genetic, lifestyle, and environmental factors are being explored—current thinking suggests that multiple causes are likely to blame, including a number of genetic pathways and environmental chemical exposures, or their interaction [18–20]. The widespread availability of air pollution exposure data generated from decades of interest in air quality’s other health effects has led to air pollution as one of the more-studied candidate ASD environmental risk factors.
However, a systematic review and meta-analysis of the evidence for the relationship between air pollution and ASD had been lacking. While systematic review methods have been used for decades in the clinical sciences [21, 22], such methods have only recently been developed and utilized in environmental health sciences [23–30]. Therefore, we applied the Navigation Guide review methodology [23, 26] to answer the question “does developmental exposure to air pollution affect diagnosis of ASD?”
The Navigation Guide Systematic Review Methodology
To conduct our review of ASD and air pollution we applied the Navigation Guide, a systematic and transparent methodology for synthesizing the available scientific evidence [23, 26]. The Navigation Guide systematic review methodology is based on Cochrane/GRADE methods [21, 22] and includes all the same elements (protocol, development, risk of bias evaluation, evidence evaluation, etc.) but accounts for the differences in evidence and decision context inherent to environmental health assessments, i.e., the reliance on human observational studies in the absence of randomized controlled trials (RCTs), and the fact that population exposure to exogenous chemicals precedes evidence of their safety. To date, the Navigation Guide method has been used in 3 case studies [25, 27, 28].
We assembled a diverse team of reviewers in August 2014 with expertise in epidemiology, air pollution/exposure assessment, ASD outcome assessment, biostatistics, library sciences, and/or systematic review methodology. We developed a protocol to outline the process for conducting the systematic review prior to initiating the study and registered the protocol with an international database for systematic reviews in March 2015. Each member of the review team also filled out a conflict of interest statement at the initiation of their involvement with the protocol to document any potential financial or other conflicts of interest, and these were appended to the protocol. Each of the protocol steps are described below and the protocol is available on PROSPERO (http://www.crd.york.ac.uk/PROSPERO/; CRD # 42015017890).
Specify the study question.
Our objective was to answer the question: “Does developmental exposure to air pollution affect diagnosis of Autism Spectrum Disorder (ASD)?”
We developed a “Participants”, “Exposure,” “Comparator” and “Outcomes” (PECO) statement, as follows:
Exposure: Any developmental exposure to air pollution that occurred prior to the ASD assessment.
- “Any developmental exposure” is defined as maternal or paternal exposure incurred any time “in proximity to” conception (as defined by authors of the included study), or exposures to offspring incurred in utero or in the perinatal or childhood period.
- “Air pollution” is defined as any indoor or outdoor source of any inhaled airborne environmental chemical, EXCLUDING active and passive smoking.
- Exposures “prior to the ASD assessment” include direct and proxy measures for this time period.
Comparator: Humans exposed to lower levels of air pollution than the more highly exposed humans.
- This definition is intended to include groups defined by ASD case-control studies; for instance comparing the air pollution exposure levels for people with ASD versus those without.
Outcome: Any clinical diagnosis or other continuous or dichotomous scale assessment of ASD.
- Clinical ASD diagnosis can be based on the International Classification of Diseases (ICD) 9, ICD 10, Diagnostic and Statistical Manual of Mental Disorders (DSM) 5, or DSM-IV criteria, including difficulties in social interaction, verbal and nonverbal communication and repetitive behaviors.
Select the Evidence.
Search methods. Our search was not limited by language or start-date of publication. We searched several online databases (PubMed, ISI Web of Science, Biosis Previews, Embase, Google Scholar, and Toxline) between November 3–5, 2014 using the search terms in S1 Table. We used the Medical Subject Headings (MeSH) database to compile synonyms for air pollution and ASD-related outcomes (http://www.ncbi.nlm.nih.gov/mesh/68000397, http://www.ncbi.nlm.nih.gov/mesh/68001321). We separated the exposure-related search into two general categories: one based on the route of exposure (air inhalation, along with appropriate synonyms in a Boolean search using the “OR” statement) and the other based on typical chemical composition of air pollution (ozone, particulate matter, etc. in a Boolean search using the “OR” statement). We intentionally crafted a broad search strategy for exposure to capture all studies evaluating any indoor/outdoor chemical air pollutant for inclusion, excluding those related to cigarette smoke. These two categories of search terms were then combined in a Boolean search using the “OR” statement to create the collection of exposure search terms. For the outcome, we combined “autism spectrum disorder” and its synonyms in a Boolean search using the “OR” statement (S1 Table).
We then combined the exposure and outcome terms using a Boolean search using the “AND” statement. We searched for terms in titles and abstracts (using the [tiab] function in PubMed, topic search in Web of Science and Biosis Previews; “ti,ab.” function in Embase) or in MeSH headings (using the [mh] function in PubMed). We searched additional toxicological websites and grey literature databases (S2 Table) intended to capture papers and reports from the non-peer reviewed literature (November 6–13, 2014). We performed “snowball searching,” which included hand-searching the reference lists of all included studies as well as review articles identified in the screening process, and using Web of Science to search for articles that cited the included studies. We also reached out to a group of recognized experts in this field from the Environmental Epidemiology of Autism Research Network (EEARN) in March 2015 to request review of the included studies to identify whether we had missed any relevant studies.
Study selection criteria. We included studies only if: 1) the report contained original data from human studies; 2) there was a measure or report of air pollution exposure prior to the diagnosis or assessment of ASD; and 3) there was a comparator (control group or exposure range comparison). References that did not meet all of these criteria were excluded from consideration (S3 File).
We screened references in duplicate for inclusion using structured forms in DRAGON (ICF International; available at: http://www.icfi.com/insights/products-and-tools/dragon-online-tool-systematic-review) and DistillerSR (Evidence Partners; available at: http://www.systematic-review.net). To determine eligibility, each reference from the literature search had the title and abstract independently reviewed by two of the five reviewers (ND, AH, AK, LD, GW) in a non-random assignment to ensure that the same two authors did not always screen the same references. In the event that an abstract was missing or there were discrepancies between the two reviewers, the default was to move the reference forward for full text review. Two of the five reviewers (ND, AH, AK, LD, GW) then independently performed a full-text review to evaluate inclusion criteria of each reference not excluded by title/abstract screening. An additional reviewer (PS) screened five percent of the titles/abstracts and full-texts for quality assurance.
Data collection and management. Four authors (ND, LD, PS, EK) and a UCSF research assistant (HT) independently extracted data relating to study characteristics and outcome measures (S3 Table) from all included articles into a DRAGON database. We contacted the corresponding author when information pertinent to our study question was missing or. A third author (JL) performed QA/QC on all of the studies by reviewing the studies and its extracted data to check for accuracy.
Reviewing the evidence.
Assessing the risk of bias for each included study. We assessed risk of bias for each included study using a modified instrument we developed based on the Cochrane Collaboration’s “Risk of Bias” tool and the Agency for Healthcare Research and Quality’s (AHRQ) domains, i.e., selection bias, confounding, performance bias, attrition bias, detection bias, and reporting bias [21, 31]. We modified the wording and instructions for several of these domains beforehand to make it specific for our study question and the types of evidence or study characteristics that we anticipated.
In particular, because of the complexity of methods for assessing exposure to air pollution, we ultimately developed a novel risk of bias instructions for exposure assessment that specified a list of important considerations, i.e., modeling, monitoring, biomarkers, etc. Review authors developed this tool collectively and in collaboration with a known expert in the air pollution field (HC) as well as the EEARN working group. Review authors were instructed to separately rate the exposure assessment risk of bias for each air pollutant chemical or classes of chemicals reported in the study under review. The justification for this was based on empirical evidence demonstrating that similar exposure assessment methods for different air pollutant compounds are heterogeneous in terms of their internal validity [32, 33]. We also elicited expert opinions from the EEARN working group to develop a list of potentially important confounders or effect modifiers to include in the analysis. These are outlined in the protocol in the risk of bias tool, under the confounding domain, along with justification for inclusion and relevant citations.
We assigned each risk of bias domain as “low,” “probably low,” “probably high,” or “high” risk of bias, or “not applicable” (risk of bias area not applicable to study) according to specific criteria as described in our risk of bias instruments (S2 File). Two of the eight review authors with subject-matter expertise (GW, AH, CN, AK, CL, TW, PS, EK) independently recorded risk of bias determinations for each included study. In the event that one of the review authors was a coauthor of the study in question, they recused themselves from rating the risk of bias for that particular study. We held an in-person meeting to review rationales and ratings for each study and come to consensus. Based on this discussion, two review authors (JL, EK) subsequently reviewed ratings for all included studies to ensure consistency across studies with similar study populations or study design.
Statistical analyses. We assessed study characteristics from included articles to evaluate comparability of findings based on pre-determined features as outlined in our protocol (i.e., study features, study population, exposure assessment method, and outcome assessment method) to determine which study results were potentially suitable for meta-analysis. In particular, review authors had decided beforehand that different air pollutant chemicals or classes of compounds (i.e., heavy metals, pesticides, and criteria air pollutants) should be analyzed separately in the absence of empirical evidence to suggest that we could combine these effect estimates. From the assessment of specified characteristics, we determined that two subsets of studies in which exposure was measured during pregnancy or prior to assessment of ASD met these criteria. The first was for particulate matter less than 10 μm (PM10) (comprised of six studies), and the second was for fine particulate matter, less than 2.5 μm (PM2.5) (comprised of three studies), from studies where exposure was measured during pregnancy prior to diagnosis or assessment of ASD.
PM10 or PM2.5 concentrations and their standard errors (reported in the study or calculated from reported 95% confidence interval and sample sizes) were extracted from each study for the meta-analysis. We extracted adjusted odds ratio (OR) estimates reported for a continuous increment increase in exposure, then standardized effect estimates across all studies by computing adjusted OR estimates per 10 μg/m3 increase in PM. In the event that such an estimate was unavailable or could not be calculated from the data available in the published article, we contacted study authors to request these data be made available to us. We then combined the standardized effect estimates from each study in a random effects model with inverse variance weighting. The result was an estimate of the combined summary OR per 10 μg/m3 increase in PM, accounting for within- and between-study variability. We used R statistical software (version 3.0.1) and the “metafor” package for analyses.
We evaluated statistical heterogeneity across study estimates in the meta-analysis using Cochran’s Q statistic with p≤0.05 as our cut off for statistical significance and I2 , as previously described [24, 27, 30]. If statistical heterogeneity was present, we used leave-one-out analysis to identify the study or studies contributing, evaluated potential study characteristics (for example, study location, study population, study design, adjusted confounders, timing of exposure, etc.) to explain the source, and incorporated hierarchical cluster structures in the data analysis to statistically account for the heterogeneity.
Although data for other contaminants were not amenable to a meta-analysis due to insufficient number of studies and/or the existence of heterogeneity across study characteristics, we created scatterplots of effect estimates by contaminant to visually inspect these results and evaluate associations.
Rating the quality of evidence across all included studies. We rated the quality of the overall body of evidence as either”high,”“moderate” or”low.” The Navigation Guide approach follows that established by the Grading of Recommendations Assessment Development and Evaluation (GRADE) method used in the clinical field; i.e., by first assuming an initial quality rating to the body of evidence and then considering adjustments (“downgrades” or “upgrades”) based on the characteristics of the included studies to reach a final quality rating .
We assumed an initial rating of “moderate” quality to the human bodies of evidence (observational studies), based on previously described rationale  and consistent with previous case studies [27, 28, 30], based on consideration of both the values and limitations of observational data in assessing associations between exposure and health outcomes in environmental health. We considered downgrades and upgrades to this initial quality rating based on 8 specific factors and instructions for consideration (S4 Table): risk of bias, indirectness of evidence, inconsistency of evidence, imprecision of evidence, potential for publication bias, large magnitude of effect, dose response relationship, and whether residual confounding would minimize the overall effect estimate. Possible ratings were 0 (no change from initial quality rating), -1 (1 level downgrade) or– 2 (2 level downgrade); +1 (1 level upgrade) or + 2 (2 level upgrade). Review authors independently evaluated the quality of the evidence and then compared their ratings and rationale for each quality category. We discussed our ratings as a group and recorded our rationale. Consistent with GRADE, we did not automatically add together the ratings for each downgrade and upgrade factor to create a score, e.g., a (-1) downgrade for each of 2 factors does not necessarily translate into a (-2) downgrade overall. We used our judgment to decide the weight of each downgrade or upgrade in the final overall quality rating.
Rating the strength of the evidence across all included studies. We rated the overall strength of the body of evidence based on 4 considerations: (1) Quality of body of evidence (i.e., the rating from the previous step); (2) Direction of effect; (3) Confidence in effect (likelihood that a new study would change our conclusion); and (4) Other compelling attributes of the data that may influence certainty. We used these considerations to assign the overall strength rating, according to the definitions specified in the Navigation Guide for “sufficient evidence of toxicity,” “limited evidence of toxicity,” “inadequate evidence of toxicity,” or “evidence of lack of toxicity” (Table 1), which are based on categories used by the International Agency for Research on Cancer (IARC) , with the definitions of each category based on IARC, the U.S. Preventive Services Task Force, and U.S. EPA for evidence integration [35–38]. Review authors independently evaluated the strength of the evidence and compared their evaluations, resolved discrepancies by discussion, and recorded the collective rationale for decisions.
We retrieved a total of 1,155 references from our literature search, of which 96 met inclusion criteria based on title and abstract screening and 20 further met inclusion criteria based on full text screening [39–58]. We also identified three additional studies [59–61] by consulting with experts in the field (those affiliated with the EEARN listserve) who reviewed our list of included studies to determine whether there were additional studies that had not yet been identified, bringing the total number of screened references to 1,158 and the total number of included studies to 23 (Fig 1). Some of these studies initially had multiple separate records—for instance, a conference abstract plus a subsequently published manuscript; the information from these records was ultimately collectively assessed using information from the peer-reviewed manuscript supplemented by further relevant details from the additional records if applicable. The 23 included studies were all published between the years 2006 to 2015, included 174 to 4,057,712 participants born between the early 1990s through 2005, were based in 4 different countries, and involved case-control, cohort, and ecological study designs (Table 2). All but one study published in Spanish  were in English.
Risk of bias assessment for individual studies
Overall, most studies were rated as “low” or “probably low” risk of bias in most domains other than the confounding and exposure assessment domains (Fig 2). Many of the studies rated as “probably high” (with one “high”) for potential confounding were due to the failure to adjust for many of the important confounders that we had established beforehand in our protocol. We rated exposure assessment risk of bias separately for each air pollutant or class of components within each study. Overall, we rated 103 different air pollutant chemicals (such as formaldehyde, PM2.5, ozone, etc.) and chemical classes (such as pesticides, fumigants, traffic-related pollutants, etc.). Only 21 of these chemicals or chemical classes were reported in ≥3 studies. Many of the contaminants that were ultimately rated as having “high” risk of exposure assessment bias used data from the US EPA National-scale Air Toxics Assessment (NATA), Toxic Release Inventory (TRI), or self-reported from surveys. We rated risk of exposure assessment bias for each air pollutant that used NATA data following published guidance that had already established the degree of confidence in each individual NATA contaminant estimate by comparing to monitored air pollution values [62, 63]. Following this guidance, our initial exposure assessment risk of bias ratings for NATA data were assigned as “probably low” for those with “higher confidence” (i.e., benzene, acrylonitrile, carbon tetrachloride, etc.), “probably high” for those with “medium” confidence (i.e., coke oven emissions, vinyl chloride, chloroform, ethylene dibromide, etc.), and “high” for those with “lower” confidence (i.e., arsenic compounds, beryllium compounds, cadmium compounds, lead compounds, etc.). All the air pollutants that were based on data modeled from Toxic Release Inventory (TRI) data were rated as “probably high” risk of exposure assessment based on concerns regarding the validity of extrapolating emission quantity data to individual or community-level exposures. Ultimately, only the studies involving air pollutants of PM10, PM2.5, ozone and methylene chloride were rated as “probably low” risk of bias (Fig 2b). Additional detail on individual study characteristics and risk of bias designation/rationale is presented in the S5 Table.
Of the 23 included studies, six studies that measured PM10 and three that measured PM2.5 (a subset of the six with PM10 data) were amenable to meta-analyses. One additional included study  also reported effect estimates for both PM10 and PM2.5 but ultimately was not included in the meta-analysis because upon personal communication with the study authors  it was determined that the study population was a subset of the population reported in a previous article  that was already included in the meta-analyses. Furthermore, although included studies evaluating ozone and methylene chloride exposure were rated as “probably low” risk of bias and therefore potentially could have been incorporated into a meta-analysis, upon review there were limited studies (4 each) measuring exposure using varied metrics (environmental monitoring, emissions-based modeling, using occupation as surrogate for exposure) that were deemed too heterogeneous to combine into a meta-analysis.
All studies included in the meta-analyses measured PM exposure levels either through national or state air quality monitoring stations (i.e., US Environmental Protection Agency Air Quality System, California Air Resources Board monitor stations, or Taiwan EPA monitoring stations) or through historical emissions databases, combined with dispersion models to estimate residential levels of pollutants. Study population sizes ranged from 524–83,229. Study populations came from a variety of cohorts and regions, primarily in the U.S., such as the Nurses’ Health Study II, U.C. Davis’ Childhood Autism Risks from Genetics and the Environment (CHARGE) study, the Center for Diseases Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network, Child and Adolescent Twin Study in Sweden (CATSS), or identified through insurance claims or state departments tracking ASD diagnoses. The majority of studies adjusted for maternal age, parental level of education, race/ethnicity, gender of child, household income, and some measure of socio-economic status. We contacted the corresponding author from four of the six included studies to request additional information and received responses from all four authors.
The initial meta-analyses of PM10 yielded a pooled OR = 1.20 (95% CI: [1.00, 1.42]). However, there was considerable statistical heterogeneity in the pooled estimate (I2 = 77%, p-value = 0.007). Although the overall number of studies was small, leading to uncertainty in the heterogeneity estimate, the 95% confidence interval for the I2 estimate (20–98%) suggested that heterogeneity was of concern. Using a leave-one-out analysis, we identified one study in particular  that was contributing to the majority of this heterogeneity. We contrasted design characteristics of this study with those of the other included studies to determine if the statistical heterogeneity could be explained by differences on a key characteristic; however, we concluded that the statistical heterogeneity was largely unexplained. We added in a hierarchical cluster structure to include this study as a separate cluster from all other studies, and this greatly reduced the unexplained heterogeneity (I2 = 2%, p-value = 0.41), indicating that with this clustered analysis statistical heterogeneity was of minimal concern. Based on this clustered meta-analysis, we found an overall effect estimate of OR = 1.07 (95% CI: [1.06, 1.08]) per 10-μg/m3 increase in PM10 (Fig 3).
We also conducted sensitivity analyses to assess the robustness of the positive relationship between PM10 exposure and risk for ASD. We estimated the hypothetical effect estimates needed from a single additional included study that would shift our meta-analysis to where: 1) the 95% confidence interval of the meta-analysis overlaps the value 1 (loses statistical significance), and 2) the summary effect estimate becomes less than 1. For both scenarios we assumed that the additional study would have a standard error of 0.04, equal to the smallest in our group of studies . We found that an additional new study would need to have an effect estimate of OR = 1.03 to enlarge our confidence interval to overlap 1, and OR = 0.44 to shift our overall effect estimate to OR<1. The former OR estimate is reasonably within the range of that reported by existing studies (thus, it might be possibly for a new study to easily shift our interpretation of statistical significance of the overall effect estimate), but the OR required to shift the overall effect estimate to OR<1 seemed rather unlikely.
For PM2.5, the summary effect estimate was OR = 1.88 (95% CI: [1.11, 3.20]) but, similar to PM10 analyses, we found evidence of considerable statistical heterogeneity (I2 = 96%; p-value<0.0001). Again using a leave-one-out analysis, we identified one study in particular  that was contributing to the majority of the heterogeneity and we could not identify particular methodological features driving the heterogeneity so we classified it as unexplained. Adding in a hierarchical cluster structure here greatly reduced the unexplained heterogeneity (I2 = 0%, p-value = 0.54), indicating that with this clustered analysis statistical heterogeneity was of minimal concern. Based on this clustered meta-analysis, we found a pooled effect estimate of OR = 2.32 (95% CI 2.15 to 2.51) per 10-μg/m3 increase in PM2.5 (Fig 4). Sensitivity analyses here (assuming the added hypothetical study would have a standard error of 0.04, equal to the smallest in our group of studies ) found that an added study would need an effect estimate of OR = 1.02 to enlarge the confidence interval to overlap 1, and an OR = 0.14 to shift the overall effect estimate to OR<1. The former OR estimate is outside the range of that reported by existing studies, but not unreasonably so; however, the OR required to shift the overall effect estimate to OR<1 seems quite unlikely.
For all other air pollutant chemicals or classes of chemicals with effect estimates reported for ≥3 studies, we generated scatter plots of reported data (S1 Fig). Odds ratio (OR) or relative risk (RR) estimates were plotted on the log-transformed scale by chemical and separated by categories of “general air pollutants” (including diesel particulate matter, nitrogen dioxide, and ozone), “industrial chemical pollutants” (including benzene, ethylbenzene, methylene chloride, perchloroethylene, styrene, toluene, trichloroethylene, and vinyl chloride), “heavy metal air pollutants” (including arsenic, cadmium, chromium, lead, nickel, manganese, and mercury). We also created a scatterplot for “pesticide air pollutants,”, combining all individual pesticides (e.g., acrolein) with grouped categories (e.g., organophosphates). We generally observed a trend towards positive effects (increasing exposure associated with increased autism risk), although there were limited data and confidence intervals commonly overlapped the null. The other air pollutants most consistently reporting statistically significant associations with of ASD included heavy metals with exposures assessed using NATA data. However, for many of these air pollutants, serious risk of bias existed for exposure assessment with one or more studies rated as “high” or “probably high” (Fig 2).
Quality and strength of the overall body of evidence
We rated the quality of the human evidence as “moderate.” Our decisions leading to this rating were primarily based on the concern that many of the air pollutant chemicals or classes had exposure assessment methods that were rated “high” or “probably high” for risk of bias for exposure assessment methods (rated as between “0 to -1”) (Table 3). There was insufficient number of studies to utilize funnel plot analyses to assess publication bias quantitatively; so we based our decision to not downgrade for publication bias on the fact that we conducted a comprehensive search, found studies from the grey literature, and found studies of variable sizes, designs, and funding sources that had similar findings. We found insufficient evidence to upgrade the body of evidence. Ultimately, although there was concern regarding the risk of bias domain, we did not judge this to be sufficient enough to warrant downgrading the evidence and therefore remained at the initial “moderate” rating.
We rated the final overall strength of the evidence as “limited” (Table 2). While the meta-analysis suggested statistically significant effects for PM, these were based on very few studies and sensitivity analysis suggested that even a single added study within the range of ORs reported in the body of research to date could lead to a summary effect evidence that did not attain statistical significance (although an extreme OR estimate would be require to change the direction of the overall effect estimate to below 1). Further the occurrence of heterogeneity that lacked a clear methodological rationale is suggestive of randomness in the available data, was concerning to review authors, and this was influential in our final rating of “limited” overall evidence.
We conducted the first systematic review and meta-analysis of the body of human evidence to assess whether early life exposure to ambient air pollutants is associated with ASD. We concluded that there was “limited evidence of toxicity” for the association between early life exposure to air pollution as a whole and diagnosis of ASD. The strongest evidence supported an association between exposure to particulate matter and ASD. We utilized six robust studies (five case-control and one cohort) with minimal risk of bias concerns that represented a total of 9,557 children with autism and 143,997 controls reporting on PM10 exposure, and a subset of these that also reported on PM2.5. These studies reported effect estimates similar enough to be combined into a meta-analysis we found statistically significant pooled effect estimates for both PM components, with a stronger effect demonstrated for PM2.5 than for PM10. We identified statistical heterogeneity in our meta-analysis that could be minimized through incorporating a clustered data analysis structure, but not explained through differences in study design. We determined through sensitivity analysis that future studies comparable to the ones included in our review (i.e., with similar effect estimates and uncertainty) could potentially change the strength of the relationship between PM and ASD estimated from the meta-analysis. In other words, the effect of particulate matter on ASD may be stronger or weaker than these results indicate. However, we found that it would be unlikely that a future study would change the direction of the association between PM and ASD, for example moving air pollution from being a risk factor for ASD to being health protective for ASD. Generally, the other air pollutants that could not be combined into a meta-analysis (such as some of the metal air pollutants) supported positive and statistically significant effects, although the effects were generally small and not consistent. Collectively, these findings led to our conclusion that positive relationships were observed between air pollution exposures generally and ASD, but that chance, bias, and confounding could not be ruled out with reasonable confidence because of the limitations present in the available data. This met our definition of “limited evidence of toxicity” for the association between early life exposure to air pollution generally and ASD.
Our systematic review and meta-analysis had several strengths. This is the first example of applying a systematic approach and combining evidence into a meta-analysis to evaluate the body of evidence for all types of air pollutants collectively. The Navigation Guide approach is based on the GRADE principles  for rating the quality and strength of the evidence and incorporates similar criteria and considerations for evaluation, with slight modifications for application to environmental health evidence—in particular, the lack of randomized control human trials. The GRADE approach requires judicious consideration of the contribution of each study to addressing the study question, with general guidance to focus on the high-quality studies—in this case the evidence supporting the link between PM and ASD. However, evidence from all other air pollutant studies were also considered when evaluating the quality and strength of the evidence—for instance, determining whether the studies overall contributed direct evidence to answer the study question or whether the study estimates demonstrated a large magnitude of effect.
Our systematic review results were generally in concert with previous expert-based narrative reviews that addressed the association of ASD and environmental chemical exposures more broadly [18, 65–67]. The only prior review of air pollutants and neuropsychological development that followed a prescribed systematic methodology was limited to published English language studies appearing during or after 2012 and did not include a meta-analysis . The authors of this review rated evidence based on IARC classifications and concluded that there was “sufficient” evidence for an association of ASD with PM2.5. The Navigation Guide classifications are based largely on the IARC classifications. However, our review additionally included a meta-analysis, the results of which further demonstrated an association between air pollution (PM) and ASD, but also revealed some uncertainties in the body of evidence that would not have been apparent except for the meta-analysis. The unexplained heterogeneity in the meta-analysis led us to conclude that the body of evidence fit the definition of “limited toxicity” better than the definition of “sufficient toxicity.”
Several newer studies have been published since the end-date of our search, including a European multi-site study combining different scale measurements of ASD symptoms, which reported no association between particulate matter or nitrogen dioxide and autistic traits  and two studies from a case-control sample in Pennsylvania, reporting an association between PM2.5 and ASD  and between some air toxics and ASD . We do not know for certain how these studies would impact our review results without a formal evaluation of their risk of bias and integration of these studies into the overall rating of quality and strength of the evidence. However, we note that the effect estimates reported for PM in these studies generally fall within the range of those reported by the studies included in our meta-analysis.
Together, these findings support the hypothesis that early life exposure to air pollution may contribute to ASD. While some studies have suggested a strong genetic heritability contribution to ASD development, these do not fully explain the recent increases in ASD prevalence and thus environmental risk factors are recognized as playing a strong contribution to the increase in ASD [72–76]. Exposure to chemicals in air pollution may act through several potential pathophysiological mechanisms related to immune function, endocrine disruption, and epigenetic alterations . These mechanisms vary greatly by chemical air pollutant—for instance, particulate pollutants (complex chemical mixtures solely defined by size, such PM2.5) are able to penetrate deep into the lungs and can enter blood circulation, where they can induce oxidative stress leading to inflammatory responses that subsequently result in the perturbation of neurodevelopment . In contrast, other specific chemical constituents of air pollution, such as metals, may impact neurodevelopment of the developing fetus through direct exposure, or cause an elevation in inflammatory cytokines in the maternal circulation that subsequently impacts neurodevelopment [66, 78, 79]. While there are many outstanding questions about the nature and extent of the association of air pollution and ASD specifically, there is already strong evidence that certain air pollutants such as PM, lead, and mercury impact brain development [76, 80–82]. Our review identified research gaps that should inform future work on this topic. Further, we provide a concise statement of the strength of the evidence, which decision-makers and policymakers can use to integrate with other factors that are important in setting decisions, such as values and preferences about the outcome, alternatives to avoiding the outcome, and the costs and benefits of action.
Advancing ASD and Air Pollution Research
The limitations identified in this body of evidence reveal gaps in the current scientific literature and point the way for optimizing future research related to the environmental contributors to ASD specifically, and air pollution in general. In particular, future research should account for the following:
- Challenges in assessing exposure to the complex mixture that defines air pollution. The available evidence was not readily combinable in a meta-analysis because air pollution exposure was assessed through many different and non-standardized metrics and included data on over 100 different chemical components or surrogate measures of air pollution. While the PM data and several other pollutants were rated as low risk of bias (i.e., ozone, methylene chloride), only the PM data was sufficient for inclusion in a meta-analysis. Many of the other air pollutant exposures were classified as probably high or high risk of bias, with some being based on surrogate measures (i.e., distance to freeway) or lacking accounting for time-activity patterns or spatial accuracy. Studies also varied widely in terms of the methods (monitoring, modeling, etc.) and data source (NATA, TRI, etc.) used to assess exposure. Most studies assigned exposure based on birth address, which implies prenatal exposure, but may not reflect addresses earlier in pregnancy. Notably, some studies improved on this by obtaining a residence history from participants; future studies could potentially utilize tracing services to gather this important information. This is a generic challenge that will likely be present for the majority of air pollution studies, but recent advances in assessment methods such as use of portable personal sensors and exposomic technologies could make a significant impact. To increase the usefulness of study results to decision-making, investigators need to directly address these challenges and maximize the accuracy and applicability of exposure measurements to the target population.
- Challenges related to study design. The included studies varied in the adjusted confounders considered, the timing of exposure or outcome measurement, and the method used for assessing the ASD outcome. Such heterogeneity makes it difficult to combine the results of multiple studies, as there is little empirical basis available to inform how variations in these study characteristics might impact the reported effect estimates. There is a need to establishing basic criteria for environmental studies of ASD based on an improved understanding of how different adjustment factors and timing or method of exposure and outcome in the same population impact effect estimated to maximize the potential for combining studies relevant to the same research question.
- Challenges related to reporting. Many effect estimates were reported on different scales or categorized the exposures using different ranges. As such, with the exception of PM, where estimates could fairly easily be standardized, the body of evidence was disparate and largely not combinable. Future studies should increase availability of raw data or broaden reporting of effect estimates using different metrics to ensure statistical combinability in future meta-analyses.
- Challenges related to unexplained heterogeneity. In meta-analyses, PM demonstrated statistically significant summary associations with ASD. We observed a larger summary effect estimate for PM2.5 (OR = 2.32) than for PM10 (OR = 1.20). Because smaller particles have the ability to penetrate into the circulatory system and are thought to be more biologically active [83–86], this pattern of association is not unexpected. Alternatively, the larger effect for PM2.5 could be related to the limited available sample of effect estimates as the Volk et al.  and Becerra et al.  studies, which generated the highest estimates for both PM10 and PM2.5, comprised two of three included studies for PM2.5 but two of six included studies for PM10. There are possible study design characteristics that differed (for instance, the availability and quality of individual home addresses to estimate individual-level exposures), but it is difficult to assign an exact explanation for the observed heterogeneity in results. Unexplained heterogeneity is troubling but could be resolved with additional studies that could reduce overall variability of estimates and which provide insight into methodological reasons behind the heterogeneity.
- The interplay between genes and the environment. One of the included studies reported an elevated risk of ASD only in those with a mutation in the MET tyrosine kinase receptor and those in the highest exposure level category . While interactions between genes and the environment are known to play a key role in ASD, relatively few studies have been able to adequately power such analyses. The Volk et al.  study illustrates the importance of considering moderating variables to evaluate heterogeneity in examining ASD etiology. This will be an important consideration in future reviews as more data emerges on this topic.
Synthesizing the Evidence for Decision-Making in Environmental Health
Our case study of applying the Navigation Guide systematic review method to synthesize the science related to ASD and air pollution underscored several key directions for evidence-based decision-making in environmental health.
- Use of novel tools for assessing risk of bias in air pollution studies. Due to the complexity of assessing the risk of bias of air pollution exposure assessments, we developed a novel risk of bias tool and piloted its use for this study. This tool is now available  and can be adapted and implemented for evaluating exposure assessment of future systematic reviews and can also serve as a guide to strategically incorporate methods that reduce potential risks of bias in future air pollution studies.
- The need for consistent and complete reporting of research results. Without the cooperation of individual study authors, it would have been impossible to complete the meta-analysis. This observation is consistent with our previous systematic reviews, [24, 27, 28, 30], and underscores the need for journal editors to routinely request consistent information from authors when manuscripts are accepted for publication to advance the capacity to conduct robust systematic reviews. To this end, several high-impact journals have already adopted the ARRIVE guidelines for animal studies (http://www.nc3rs.org.uk/ARRIVE/) [88, 89] or MOOSE guidelines for human observational studies . Our experience supports these approaches, and we recommend reporting guidelines be expanded to consider other elements pertinent to high throughput in vitro studies and other types of experimental and observational evidence.
- The need to mechanize and automate data synthesis. As with our previous systematic reviews, [24, 27, 28, 30], we found efficient ways to sort through a large number of studies captured through a broad search. Keys to this efficiency were implementing explicit predetermined inclusion/exclusion criteria and user-friendly software. We began the review using DRAGON software to perform title and abstract screening of studies but we found DistillerSR to be more flexible and easy to use and discontinued use of DRAGON. The development of increasingly capable software and other tools, including natural language processing and machine reading,  will be critical to advancing systematic reviews in clinical and environmental health.
- Time sensitive nature of systematic reviews. We had completed our review but had not yet published our results when three new relevant studies were published . This highlights the practice of establishing stopping dates for a review’s literature search, which is essential for assessments in regulatory and policy decision-making. The nature of scientific information means knowledge is always evolving, yet it is important to use stopping dates to evaluate what is known in the scientific literature at that time and use the information to make a decision based on this knowledge at hand. In the future we recommend re-running the search immediately before data analysis and planning for a very short time between data analysis and the review team’s rating of the quality and strength of the evidence. This will become increasingly feasible as more and more scientists are trained in the method and it becomes more efficient. It also highlights the need to conduct cumulative meta-analyses as more data become available, a common practice in the clinical sciences. A future research project could involve updating the search and investigating how new available studies might change our ratings and decision.
In summary, we conducted the first systematic review and meta-analysis of the literature on the association between ASD and air pollution and concluded that there was “limited evidence of toxicity.” We found the strongest available evidence was supporting associations between PM and ASD, which was supported by the results of our meta-analysis. The available body of evidence on air pollution in general and ASD was wide, shallow, and except for PM, limited in their ability to strongly support a relationship if one exists. Our rating of the quality and strength of the evidence for this study question provides insight on the current state of the science but also the research gaps to address in future studies. Accurate measurement of human exposures to air pollutants during developmentally relevant time periods remains a key limitation in this research area, calling for continued work to improve air models, explore biomarkers, and pool and expand study samples to ameliorate effects from exposure measurement error. Identifying the environmental contributors to ASD and neurodevelopment in general is a critical unmet clinical and public health need, as recognized by a recent consensus statement published by leading scientific and medical experts, along with children’s health advocates, which identifies the importance of environment as a risk factor for neurodevelopment . Furthermore, the strength of the scientific evidence is but one component of decision-making and other factors such as the co-benefits of reducing air pollution exposures and the severity of potential health outcomes should be taken into consideration when making policy and regulatory decisions. Our research findings and recommendations can support researchers, clinicians, impacted individuals, families, communities, policy-makers, and funding agencies in expediting the scientific discovery in this field as well as advancing evidence-based decision-making on how to take action to prevent future harm.
S1 Fig. Reported effects estimates scatterplots.
S2 File. Instructions for making risk of bias determinations.
S2 Table. Toxicological websites and grey literature databases searched.
S3 Table. Data extraction fields and description.
S4 Table. Factors for evaluating the overall quality of a body of evidence.
Isabel Elaine Allen
Environmental Epidemiology of Autism Research Network (EEARN) working group
- Aisha Dickerson
- Lisa Croen
- Miki Bresnahan
- Julie Daniels
- Kristen Lyall
- Laura Schieve
- Diana Schendel
- Alison Singer
- Marc Weisskopf
- Astrid Haugen
- Mady Hornig
- Dani Fallin
- Mohammed Rabhar
- Sally Ozonoff
We graciously acknowledge the following corresponding study authors for providing additional data to contribute to our meta-analysis:
Dr. Tong Gong
Dr. Bing-Fang Hwang
Dr. Raanan Raz
Dr. Heather Volk
- Conceptualization: JL PS AH TW GW.
- Data curation: JL.
- Formal analysis: JL TW.
- Funding acquisition: JL PS AH ND TW.
- Investigation: JL PS AK AH EK CL LD ND CN TW GW.
- Methodology: JL PS AK AH CL CN TW GW.
- Project administration: JL PS TW.
- Software: JL.
- Supervision: JL PS TW.
- Validation: JL PS EK LD ND.
- Visualization: JL.
- Writing – original draft: JL.
- Writing – review & editing: JL PS AK AH EK CL LD ND CN TW GW.
- 1. World Health Organization. Burden of Disease from Ambient Air Pollution for 2012 Geneva, Switzerland. Available: http://www.who.int/phe/health_topics/outdoorair/databases/AAP_BoD_results_March2014.pdf.
- 2. Chen H, Goldberg MS, Villeneuve PJ. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Reviews on Environmental Health. 2008;23(4).
- 3. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases—where worlds meet. The New England Journal of Medicine. 2010;363(13):1196–8. pmid:20860499
- 4. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, et al. Adverse cardiovascular effects of air pollution. Nature clinical practice Cardiovascular Medicine. 2009;6(1):36–44. pmid:19029991
- 5. Oberdorster G, Utell MJ. Ultrafine particles in the urban air: to the respiratory tract—and beyond? Environmental Health Perspectives. 2002;110(8):A440–1. pmid:12153769
- 6. Landrigan PJ, Sonawane B, Butler RN, Trasande L, Callan R, Droller D. Early environmental origins of neurodegenerative disease in later life. Environmental Health Perspectives. 2005;113(9):1230–3. pmid:16140633
- 7. Calderón-Garcidueñas L, Solt AC, Henríquez-Roldán C, Torres-Jardón R, Nuse B, Herritt L, et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid β-42 and α-synuclein in children and young adults. Toxicologic pathology. 2008;36(2):289–310. pmid:18349428
- 8. Freire C, Ramos R, Puertas R, Lopez-Espinosa MJ, Julvez J, Aguilera I, et al. Association of traffic-related air pollution with cognitive development in children. Journal of Epidemiology and Community Health. 2010;64(3):223–8. pmid:19679705
- 9. Wang S, Zhang J, Zeng X, Zeng Y, Wang S, Chen S. Association of traffic-related air pollution with children's neurobehavioral functions in Quanzhou, China. Environmental Health Perspectives. 2009;117(10):1612–8. pmid:20019914
- 10. Guxens M, Aguilera I, Ballester F, Estarlich M, Fernández-Somoano A, Lertxundi A, et al. Prenatal exposure to residential air pollution and infant mental development: modulation by antioxidants and detoxification factors. Environmental Health Perspectives. 2012;120(1):144–9. pmid:21868304
- 11. Calderon-Garciduenas L, Mora-Tiscareno A, Gomez-Garza G, Carrasco-Portugal MDC, Perez-Guille B, Flores-Murrieta FJ, et al. Effects of a cyclooxygenase-2 preferential inhibitor in young healthy dogs exposed to air pollution: a pilot study. Toxicologic Pathology. 2009;37(5):644–60. pmid:19638440
- 12. Campbell A, Araujo JA, Li H, Sioutas C, Kleinman M. Particulate matter induced enhancement of inflammatory markers in the brains of apolipoprotein E knockout mice. Journal of Nanoscience and Nanotechnology. 2009;9(8):5099–104. pmid:19928188
- 13. Gerlofs-Nijland ME, van Berlo D, Cassee FR, Schins RP, Wang K, Campbell A. Effect of prolonged exposure to diesel engine exhaust on proinflammatory markers in different regions of the rat brain. Particle and Fibre Toxicology. 2010;7:12. pmid:20478040
- 14. Levesque S, Taetzsch T, Lull ME, Kodavanti U, Stadler K, Wagner A, et al. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environmental Health Perspectives. 2011;119(8):1149–55. pmid:21561831
- 15. van Berlo D, Albrecht C, Knaapen AM, Cassee FR, Gerlofs-Nijland ME, Kooter IM, et al. Comparative evaluation of the effects of short-term inhalation exposure to diesel engine exhaust on rat lung and brain. Archives of Toxicology. 2010;84(7):553–62. pmid:20467864
- 16. Centers for Disease Control and Prevention. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2010. Morbidity and Mortality Weekly Report (MMWR). 2014;63(SS02):1–21.
- 17. Croen LA, G J.K.; Hoogstrate J.; Selvin S. The Changing Prevalence of Autism in California. Journal of Autism and Developmental Disorders. 2002;32:207–15. pmid:12108622
- 18. Lyall K, Schmidt RJ, Hertz-Picciotto I. Maternal lifestyle and environmental risk factors for autism spectrum disorders. International Journal of Epidemiology. 2014;43(2):443–64. pmid:24518932
- 19. Kim YS, Leventhal BL. Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders. Biological Psychiatry. 2015;77(1):66–74. pmid:25483344
- 20. Mandy W, Lai MC. Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition. Journal of Child Psychology and Psychiatry. 2016;57(3):271–92. pmid:26782158
- 21. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [Updated March 2011] 2011 [May 1, 2016]. Available from: www.cochrane-handbook.org.
- 22. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. The BMJ. 2008;336(7650):924–6. pmid:18436948
- 23. Woodruff TJ, Sutton P, The Navigation Guide Working Group. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Affairs. 2011;30(5):931–7. pmid:21555477
- 24. Koustas E, Lam J, Sutton P, Johnson PI, Atchley DS, Sen S, et al. The Navigation Guide—evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environmental Health Perspectives. 2014;122(10):1015–27. pmid:24968374
- 25. Lam J, Koustas E, Sutton P, Johnson PI, Atchley DS, Sen S, et al. The Navigation Guide-evidence-based medicine meets environmental health: Integration of animal and human evidence for PFOA effects on fetal growth. Environmental Health Perspectives. 2014;122(10):1040–51. pmid:24968389
- 26. Woodruff TJ, Sutton P. The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes. Environmental Health Perspectives. 2014;122(10):1007–14. pmid:24968373
- 27. Vesterinen HM, Johnson PI, Atchley DS, Sutton P, Lam J, Zlatnik MG, et al. Fetal growth and maternal glomerular filtration rate: a systematic review. Journal of Maternal-Fetal and Neonatal Medicine. 2014:1–6.
- 28. Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim A, et al. Application of the Navigation Guide Methodology: Systematic review of the evidence for developmental and reproductive toxicity of triclosan. Environment International. 2016;Epub ahead of print.
- 29. Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA. Systematic review and evidence integration for literature-based environmental health science assessments. Environmental Health Perspectives. 2014;122(7):711–8. pmid:24755067
- 30. Johnson PI, Sutton P, Atchley DS, Koustas E, Lam J, Sen S, et al. The Navigation Guide—evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environmental Health Perspectives. 2014;122(10):1028–39. pmid:24968388
- 31. Viswanathan M, Ansari M, Berkman N, Chang S, Hartling L, McPheeters L, et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. 2012 AHRQ Publication No. 12-EHC047-EF.
- 32. Rosenbaum ASA D.A.; Woodruff T.J.; Wei Y.H.; Ligocki M.P.; Cohen J.P. National estimates of outdoor air toxics concentrations. Journal of the Air & Waste Management Association. 1999;49(10):1138–52.
- 33. US Environmental Protection Agency. Limitations in the 1996 National-Scale Air Toxics Assessment: Uncertainty Washington, DC2002 [Accessed 24 December 2015]. Available: http://archive.epa.gov/airtoxics/nata/web/html/conf.html.
- 34. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology. 2011;64(4):401–6. pmid:21208779
- 35. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: Preamble (amended January 2006) Lyon, France: World Health Organization; 2006. Available: http://monographs.iarc.fr/ENG/Preamble/index.php.
- 36. U.S. Environmental Protection Agency. Guidelines for Developmental Toxicity Risk Assessment Washington, DC: U.S. Environmental Protection Agency; 1991 [Accessed 27 February 2014]. Available: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=23162#Download.
- 37. U.S. Environmental Protection Agency. Guidelines for reproductive toxicity risk assessment Washington, DC: U.S. Environmental Protection Agency; 1996 [Accessed 27 February 2014]. Available: http://www.epa.gov/raf/publications/pdfs/REPRO51.PDF.
- 38. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D. Update on Methods: Estimating Certainty and Magnitude of Net Benefit: U.S. Preventive Services Task Force 2007. Available: http://www.uspreventiveservicestaskforce.org/uspstf07/methods/benefit.htm#copyright.
- 39. Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B. Ambient air pollution and autism in Los Angeles county, California. Environmental Health Perspectives. 2013;121(3):380–6. pmid:23249813
- 40. Blanchard KS, Palmer RF, Stein Z. The value of ecologic studies: mercury concentration in ambient air and the risk of autism. Reviews on Environmental Health. 2011;26(2):111–8. pmid:21905454
- 41. Gong T, Almqvist C, Bolte S, Lichtenstein P, Anckarsater H, Lind T, et al. Exposure to Air Pollution From Traffic and Neurodevelopmental Disorders in Swedish Twins. Twin Research and Human Genetics. 2014;17(6):553–62. pmid:25229653
- 42. Jung CR, Lin YT, Hwang BF. Air Pollution and Newly Diagnostic Autism Spectrum Disorders: A Population-Based Cohort Study in Taiwan. PLOS ONE. 2013;8(9).
- 43. Kalkbrenner AE, Daniels JL, Chen JC, Poole C, Emch M, Morrissey J. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology. 2010;21(5):631–41. pmid:20562626
- 44. Kalkbrenner AE, Windham GC, Serre ML, Akita Y, Wang XX, Hoffman K, et al. Particulate Matter Exposure, Prenatal and Postnatal Windows of Susceptibility, and Autism Spectrum Disorders. Epidemiology. 2015;26(1):30–42. pmid:25286049
- 45. Lewandowski TA, Bartell SM, Yager JW, Levin L. An evaluation of surrogate chemical exposure measures and autism prevalence in Texas. Journal of Toxicology and Environmental Health, Part A. 2009;72(24):1592–603.
- 46. McCanlies EC, Fekedulegn D, Mnatsakanova A, Burchfiel CM, Sanderson WT, Charles LE, et al. Parental occupational exposures and autism spectrum disorder. Journal of Autism and Developmental Disorders. 2012;42(11):2323–34. pmid:22399411
- 47. Pino-López M, Romero-Ayuso DM. Autism Spectrum Disorders and Parental Occupational Exposures. Revista Española de Salud Pública. 2013;87(1):73–85.
- 48. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environmental Health Perspectives. 2007;115:1482–9. pmid:17938740
- 49. Roberts AL, Lyall K, Hart JE, Laden F, Just AC, Bobb JF, et al. Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants. Environmental Health Perspectives. 2013;121(8):978–84. pmid:23816781
- 50. Trousdale K. Autism Spectrum Disorder and hazardous air pollutants in the U.S. and Maryland. College Park, Maryland: University of Maryland; 2010.
- 51. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environmental Health Perspectives. 2011;119(6):873–7. pmid:21156395
- 52. Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA psychiatry. 2013;70(1):71–7. pmid:23404082
- 53. Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB. Autism Spectrum Disorder: Interaction of Air Pollution with the MET Receptor Tyrosine Kinase Gene. Epidemiology. 2014;2014(25).
- 54. von Ehrenstein OS, Aralis H, Cockburn M, Ritz B. In Utero Exposure to Toxic Air Pollutants and Risk of Childhood Autism. Epidemiology. 2014;25(6):851–8. pmid:25051312
- 55. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environmental Health Perspectives. 2006;114(9):1438–44. pmid:16966102
- 56. Windham GC, King G, Roberts E, Croen LA, Grether J. Autism and distribution of hazardous air pollutants at birth in California. Epidemiology. 2007;18(Suppl 5):S174.
- 57. Windham GC, Sumner A, Li SX, Anderson M, Katz E, Croen LA, et al. Use of birth certificates to examine maternal occupational exposures and autism spectrum disorders in offspring. Autism Research. 2013;6(1):57–63. pmid:23361991
- 58. Shelton JF, Geraghty EM, Tancredi DJ, Delwiche LD, Schmidt RJ, Ritz B, et al. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environmental Health Perspectives. 2014;122(10):1103–10. pmid:24954055
- 59. Dickerson AS, Rahbar MH, Han I, Bakian AV, Bilder DA, Harrington RA, et al. Autism spectrum disorder prevalence and proximity to industrial facilities releasing arsenic, lead or mercury. Science of the Total Environment. 2015;536:245–51. pmid:26218563
- 60. Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, et al. Autism Spectrum Disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Pediatric and Perinatal Epidemiology. 2016;Submitted.
- 61. Raz R, Roberts AL, Lyall K, Hart JE, Just AC, Laden F, et al. Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case–control analysis within the Nurses’ Health Study II cohort. Environmental Health Perspectives. 2014;123(264–270). pmid:25522338
- 62. Rosenbaum AS, Axelrad DA, Woodruff TJ, Wei YH, Ligocki MP, Cohen JP. National estimates of outdoor air toxics concentrations. Journal of the Air & Waste Management Association. 1999;49(10):1138–52.
- 63. Environmental Protection Agency U.S. (US EPA). Limitations in the 1996 National-Scale Air Toxics Assessment 2015. Available: https://archive.epa.gov/airtoxics/nata/web/html/conf.html.
- 64. Volk HE. Email correspondence. 2014.
- 65. Hertz-Picciotto I. Environmental Risk Factors in Autism: Results from Large-Scale Epidemiologic Studies. In: Amaral DG, Dawson G, Geschwind DH, editors. Autism Spectrum Disorders: Oxford University Press; 2011. p. 827–62.
- 66. Kalkbrenner AE, Schmidt RJ, Penlesky AC. Environmental Chemical Exposures and Autism Spectrum Disorders: A Review of the Epidemiological Evidence. Current Problems in Pediatric and Adolescent Health Care. 2014;44(10):277–318. pmid:25199954
- 67. Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: a systematic review. Translational Psychiatry. 2014;4.
- 68. Suades-González E, Gascon M, Guxens M, Sunyer J. Air pollution and neuropsychological development: a review of the latest evidence. Endocrinology. 2015;156(10):3473–82. pmid:26241071
- 69. Guxens M, García Esteban R, De Nazelle A, Forns i Guzman J, Nieuwenhuijsen MJ, Sunyer Deu J. Air Pollution Exposure during Pregnancy and Childhood Autistic Traits in Four European Population-Based Cohort Studies: The ESCAPE Project. Environmental Health Perspectives. 2016;124(1):133–40. pmid:26068947
- 70. Talbott EO, Arena VC, Rager JR, Clougherty JE, Michanowicz DR, Sharma RK, et al. Fine particulate matter and the risk of autism spectrum disorder. Environmental Research. 2015;140:414–20. pmid:25957837
- 71. Talbott EO, Marshall LP, Rager JR, Arena VC, Sharma RK, Stacy SL. Air toxics and the risk of autism spectrum disorder: the results of a population based case–control study in southwestern Pennsylvania. Environmental Health. 2015;14(1):80–96.
- 72. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. Journal of the American Medical Association. 2014;311(17):1770–7. pmid:24794370
- 73. Hallmayer J. Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry. 2011;68(11):1095. pmid:21727249
- 74. Lawler CP. The “environment” for autism research: signs of improvement? Environmental Health Perspectives. 2008;116(10):A416–A7. pmid:18941547
- 75. National Research Council. Scientific frontiers in developmental toxicology and risk assessment. Washington, DC: National Academies Press; 2000. xviii, 327 p. p.
- 76. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. The Lancet Neurology. 2014;13(3):330–8. pmid:24556010
- 77. Grahame TJ, Klemm R, Schlesinger RB. Public health and components of particulate matter: the changing assessment of black carbon. Journal of the Air & Waste Management Association. 2014;64(6):620–60.
- 78. Levesque S, Taetzsch T, Lull ME, Kodavanti U, Stadler K, Wagner A, et al. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environmental Health Perspectives. 2011;119(8):1149. pmid:21561831
- 79. Calderón-Garcidueñas L, Engle R, Mora-Tiscareño A, Styner M, Gómez-Garza G, Zhu H, et al. Exposure to severe urban air pollution influences cognitive outcomes, brain volume and systemic inflammation in clinically healthy children. Brain and Cognition. 2011;77(3):345–55. pmid:22032805
- 80. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. The Lancet. 2006;368(9553):2167–78.
- 81. Costa LG, Cole TB, Coburn J, Chang YC, Dao K, Roqué PJ. Neurotoxicity of traffic-related air pollution. Neurotoxicology. 2015;In press.
- 82. Costa LG, Cole TB, Coburn J, Chang YC, Dao K, Roque P. Neurotoxicants are in the air: convergence of human, animal, and in vitro studies on the effects of air pollution on the brain. BioMed Research International. 2014;2014.
- 83. Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles. British Journal of Industrial Medicine. 1980;37:337–62. pmid:7004477
- 84. De Kok TM, Driece HA, Hogervorst JG, Briede JJ. Toxicological assessment of ambient and traffic-related particulate matter: a review of recent studies. Mutation Research. 2006;613(2–3):103–22. pmid:16949858
- 85. Englert N. Fine particles and human health—a review of epidemiological studies. Toxicology Letters. 2004;149:235–42. pmid:15093269
- 86. Kampa M, Castanas E. Human health effects of air pollution. Environmental Pollution. 2008;151:362–7. pmid:17646040
- 87. Lam J, Sutton P, Halladay A, Davidson LI, Lawler C, Newschaffer CJ, et al. Applying the Navigation Guide: Case Study #4. Association Between Developmental Exposures to Ambient Air Pollution and Autism. A Systematic Review of the Human Evidence Protocol. 2014.
- 88. Tilson HAS J.C. Reporting of results from animal studies [Editorial]. Environmental Health Perspectives. 2013;121:A320–A1. pmid:24284018
- 89. Vesterinen HM, Johnson PI, Koustas E, Lam J, Sutton P, Woodruff TJ. In Support of EHP’s Proposal to Adopt the ARRIVE Guidelines. Environmental Health Perspectives. 2013;121(11–12):A325. pmid:24284027
- 90. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008–12. pmid:10789670
- 91. Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, et al. Commentary: Make sense of health data. Nature. 2015;527:31–2.
- 92. Bennett D, Bellinger DC, Birnbaum LS. Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environmental Health Perspectives. 2016;124(7):A118. pmid:27479987